REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 81 filers reported holding REPROS THERAPEUTICS INC in Q2 2013. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $51,000 | +6.2% | 5,335 | +55.3% | 0.00% | 0.0% |
| Q3 2014 | $48,000 | – | 3,435 | +85775.0% | 0.00% | – |
| Q2 2014 | $0 | -100.0% | 4 | -99.0% | 0.00% | – |
| Q1 2014 | $9,000 | -10.0% | 416 | -2.1% | 0.00% | – |
| Q4 2013 | $10,000 | -28.6% | 425 | +29.2% | 0.00% | – |
| Q3 2013 | $14,000 | -94.8% | 329 | -97.6% | 0.00% | -100.0% |
| Q2 2013 | $269,000 | – | 13,710 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,132,367 | $11,290,000 | 4.00% |
| SENZAR ASSET MANAGEMENT, LLC | 764,406 | $7,621,000 | 2.23% |
| DESTRIER CAPITAL MANAGEMENT LLC | 329,030 | $3,280,000 | 0.88% |
| RTW INVESTMENTS, LP | 229,364 | $2,287,000 | 0.85% |
| CQS Cayman LP | 700,000 | $6,979,000 | 0.46% |
| GENERAL AMERICAN INVESTORS CO INC | 508,375 | $5,068,000 | 0.40% |
| Alden Global Capital Ltd | 154,000 | $1,535,000 | 0.37% |
| J. Goldman & Co LP | 197,500 | $1,969,000 | 0.23% |
| Baker Brothers Advisors | 2,000,000 | $19,940,000 | 0.20% |
| SPHERA FUNDS MANAGEMENT LTD. | 100,000 | $997,000 | 0.17% |